126
Views
28
CrossRef citations to date
0
Altmetric
Articles

Do naturally occurring magnetic nanoparticles in the human body mediate increased risk of childhood leukaemia with EMF exposure?

Pages 569-579 | Received 02 Dec 2006, Accepted 17 Mar 2008, Published online: 03 Jul 2009
 

Abstract

Purpose: To develop the hypothesis that magnetic nanoparticles, found in many organisms and often involved in biological reactions to weak electromagnetic fields (EMF), mediate EMF-induced DNA damage which could result in increased risk of childhood leukaemia and other cancers.

Materials and methods: An analysis of current research into magnetic nanoparticles. Physics estimates and the development of the hypothesis that intracellular magnetic nanoparticles chronically change the free radical concentration and can mediate the enhanced rate of DNA damage in hematopoietic stem cells.

Results: The properties of magnetic nanoparticles are considered and the naturally occurring magnetic field generated by a magnetic nanoparticle within a cell is calculated to be in the range of about 1–200 millitesla, which exceeds the level of the natural geomagnetic field by orders of magnitude. Experiments are summarized on the biological effects of static magnetic field in this range. It is shown that magnetic nanoparticles can increase the rate of free radical formation by a few percent, in the course of an idealized radical-pair reaction in a cell. A mechanism is discussed that explains how weak alternating magnetic fields, of the order of 0.4 μT, could cause an increase in the rate of leukaemia via millitesla fields produced around superparamagnetic nanoparticles in hematopoietic stem cells.

Conclusions: The postulated presence of magnetic nanoparticles located in hematopoietic stem cells could constitute a cancer risk factor. Superparamagnetic nanoparticles can possibly mediate increased level of leukaemia caused by background exposure to low-frequency weak EMF.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.